Neoplasms, Second Primary
3
0
0
2
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Treatment Research
4 treatments under study, led by Radiotherapy
Research Leaders
5 sponsors active, led by Danish Head and Neck Cancer Group
Related Conditions
Often studied with 14 related conditions
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
0.0%
0 terminated out of 3 trials
100.0%
+13.4% vs benchmark
0%
0 trials in Phase 3/4
0%
0 of 2 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.6%
Based on 2 completed trials
Clinical Trials (3)
Palliative Primary Tumor Resection in Minimally Symptomatic Patients With Colorectal Cancer and Synchronous Unresectable Metastases
Secondary Cancer Risk After Radiation Therapy for Rectal Cancer
DAHANCA 20 Palliative Radiotherapy for Head and Neck Cancer
Research Network
Common Treatments
- Radiotherapy1
- Chemotherapy1
- No Intervention In This Retrospective Study1
- Surgery Of The Primary Tumour1
Active Sponsors
- Danish Head and Neck Cancer Group1
- Kantonsspital Graubünden1
- University of Aarhus1
- Klinik Hirslanden, Zurich1
- State Scientific Centre of Coloproctology, Russian Federation1
Top Investigators
DAHANCA (Danish Head and Neck Cancer Group)
Kantonsspital Graubünden
Related Conditions
- Neoplasms By Site1
- Colonic Disease1
- Gastrointestinal Neoplasms1
- Digestive System Neoplasms1
- Intestinal Neoplasms1